Egetis Therapeutics AB (publ) (STO:EGTX)

Sweden · Delayed Price · Currency is SEK

9.60

-0.35 (-3.52%)

Oct 13, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Emcitate	62.30M	46.10M	57.60M	21.90M	15.70M
Aladote	100.00K	-	-	-	-
Common	-	-	-	600.00K	-
PledOx	-	-	-	-	22.60M
Total	62.40M	46.10M	57.60M	22.50M	38.30M

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe (excluding Sweden)	61.50M	44.10M	-	-	-
Sweden	500.00K	500.00K	1.30M	1.90M	1.30M
Rest of the World	400.00K	1.50M	4.70M	3.00M	2.50M
Japan	-	-	14.50M	600.00K	22.60M
France	-	-	5.80M	3.90M	2.90M
Spain	-	-	5.00M	3.40M	2.90M
Great Britain	-	-	2.40M	2.50M	2.80M
Italy	-	-	2.00M	2.20M	1.00M
Poland	-	-	2.60M	1.70M	700.00K
Australia	-	-	2.50M	1.90M	1.40M
Germany	-	-	16.90M	1.60M	-
Total	62.40M	46.10M	57.70M	22.70M	38.10M